July 2, 2026 · Form 4 insider transaction
ROTHBLATT MARTINE A sold 776 shares of United Therapeutics Corporation at $553.64 per share, a transaction worth $429.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.; This transaction was executed in multiple trades at prices ranging from $553.22 to $554.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.